Biplab Lenin is a partner at Cyril Amarchand Mangaldas, one of India’s leading full-service law firms, where he is part of the Pharmaceutical, Healthcare & Life Sciences practice. With more than fifteen years of experience at the intersection of law, science, and regulation, he is widely regarded as a forward-thinking legal advisor who helps companies navigate the increasingly complex regulatory landscape governing healthcare, biotechnology, and digital health in India. His work reflects a strong commitment to staying “ahead of the curve” as emerging technologies, regulatory reforms, and global healthcare innovations reshape the legal environment for life sciences companies.

At the firm, Biplab advises a broad spectrum of clients, including pharmaceutical companies, medical device manufacturers, healthcare providers, investors, and biotechnology firms, on regulatory compliance, strategic transactions, and complex disputes. His expertise spans pharmaceutical and medical device regulation, clinical trials, digital health, nutraceuticals, intellectual property strategy, and biodiversity regulations. He has played a key role in several high-value cross-border investments and acquisitions in the life sciences sector, helping organizations align their business strategies with India’s evolving legal and policy frameworks.

What distinguishes Biplab’s perspective is his rare combination of scientific and legal training. Before entering the legal profession, he trained as an industrial biotechnology engineer, which allows him to bring a deep technical understanding to legal challenges in pharmaceuticals, biotechnology, and healthcare innovation. He later earned his LL.B. from the Indian Institute of Technology Kharagpur, equipping him with the interdisciplinary expertise needed to address complex regulatory and intellectual property issues in cutting-edge sectors.

Biplab is also a registered patent agent and a widely recognized thought leader on emerging regulatory and technology issues in healthcare. He regularly writes and speaks on topics such as digital health regulation, innovation in life sciences, and the legal implications of new healthcare technologies. His insights have been featured in leading industry platforms and legal publications, and he frequently engages with academic institutions and policy forums to shape conversations on the future of healthcare regulation.

His contributions to the legal profession have earned him recognition in several global legal rankings, including listings by Chambers & Partners Asia-Pacific, Legal 500 Asia-Pacific, and India Business Law Journal, which have acknowledged him as a rising leader in healthcare and life sciences law. Through his advisory work, thought leadership, and interdisciplinary expertise, Biplab Lenin continues to help organizations anticipate regulatory shifts and innovate responsibly in one of the most dynamic sectors of the global economy.